Aflac receives prestigious award for fight against cancer

Columbus based Aflac has received an award from the American Cancer Society (Daniel Purcell/Now Georgia)

The American Cancer Society has named Aflac the 2025 Corporate Partner of the Year. The annual recognition honors a company that has demonstrated an exceptional partnership in driving significant advancements in fundraising, educational initiatives, workplace wellness and national advocacy.

“Aflac exemplifies what is possible when a corporate partner fully aligns its purpose, leadership and resources with our mission,” said Shane Jacobson, Chief Executive Officer of the American Cancer Society. “Through a multimillion–dollar commitment and hands–on leadership engagement, Aflac has set a gold standard for corporate leadership in the fight against cancer, advancing lifesaving research, expanding access to care and strengthening support for patients and families nationwide.”

Flanked by American Cancer Society board chair Terri McClements (l.) and Chief Executive Officer Shane Jacobson (r.), Virgil Miller, president, Aflac Incorporated and Aflac U.S., and chair of the Georgia ACS CEOs Against Cancer chapter accepts the American Cancer Society 2025 Corporate Partner of the Year recognition on Monday, April 20, 2026, in Atlanta. (Photo courtesy of Aflac)

In 2025, Aflac entered a multiyear partnership with ACS to further its commitment to support and advance cancer care, with a significant focus on awareness and use of cancer screenings. According to the 2025 Aflac Wellness Matters Survey®, 90% of Americans have delayed health checkups and screenings that could help save their lives, in spite of ACS data that says for many types of cancer, early detection can significantly increase survival rates.

“As a leading provider of cancer insurance in the United States, we see firsthand how families are impacted physically, emotionally and financially by cancer every year, which makes this prestigious recognition from the American Cancer Society even more gratifying,” said Virgil Miller, president, Aflac Incorporated and Aflac U.S., and chair of the Georgia ACS CEOs Against Cancer chapter. “Aflac understands the value of investing in the promise of cancer advocacy, and we appreciate the power of working so closely with the ACS, the leading cancer-fighting organization in the nation. We are extremely proud to receive this honor.”

The company strives to increase cancer screenings, supporting ACS’s mission to improve the lives of people with cancer and their families through advocacy, research and patient support, ensuring everyone has an opportunity to prevent, detect, treat and survive cancer.

Learn more about Aflac’s partnership with the American Cancer Society at Cancer.org/Aflac.